|
May 15
|
NeuroOne Medical Technologies Second Quarter 2025 Earnings: Beats Expectations
|
|
May 13
|
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%
|
|
May 12
|
NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor
|
|
Apr 16
|
NeuroOne® Issues Letter to Shareholders
|
|
Apr 14
|
NeuroOne® OneRF® Technology Success Story Featured on Fox News
|
|
Mar 11
|
NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
|
|
Feb 12
|
NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update
|
|
Jan 3
|
NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST
|
|
Sep 5
|
NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
|
Jun 25
|
NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System
|
|
May 14
|
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
|
|
May 10
|
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
|
|
May 6
|
Favourable Signals For NeuroOne Medical Technologies: Numerous Insiders Acquired Stock
|
|
Apr 10
|
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
|
|
Apr 9
|
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
|
|
Apr 4
|
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.
|
|
Mar 26
|
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
|
|
Mar 8
|
NeuroOne® to Participate in the 36th Annual Roth Conference
|
|
Dec 7
|
NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14
|
|
May 2
|
NeuroOne® Announces U.S. Commercial Launch of Evo® sEEG Electrodes
|